Elevation of Nε-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis
Eray Yagmur, Frank Tacke, Claudia Weiss, Birgit Lahme, Michael P. Manns, Paul Kiefer, Christian Trautwein, Axel M. GressnerVolume:
39
Year:
2006
Language:
english
Pages:
7
DOI:
10.1016/j.clinbiochem.2005.07.016
File:
PDF, 352 KB
english, 2006